Living EuroGuiDerm Guideline for the systemic treatment of psoriasis vulgaris

 

The general recommendations developed in this guideline are based on the Living Cochrane review (https://pubmed.ncbi.nlm.nih.gov/35603936/). With new evidence and new results becoming available, the guideline development group will consider these and decide if and when an update is necessary. This will also be the case for the recommendations for specific clinical and comorbid situations.

 

 

Download entire guideline document in the latest version (2024):

Download
7777

Last updated
Changes
Download
Introduction, scoping, population and targeted users
09/2023
Editorial changes
Download
533
Disease severity and treatment goals
09/2023
No changes
Download
954
Methods and evidence section
09/2023
Editorial changes
Download
271
Main Recommendations and Decision Grid
09/2023
Deucravacitinib was added
Download
1325
Implementation slides
01/2024
New data added
Download
515
IFPA Guideline
09/2023
Editorial changes
Download
504

Last updated
Changes
Download
Acitretin
03/2023
No changes
Download
385
Ciclosporin
03/2023
Reference added
Download
319
Fumarates
03/2023
No changes
Download
155
Methotrexate
03/2023
New data added
Download
587
Adalimumab
03/2023
No changes
Download
272
Apremilast
03/2023
New data added
Download
337
Bimekizumab
09/2023
New data added
Download
237
Brodalumab
09/2023
New data added
Download
113
Certolizumab – Pegol
09/2023
No changes
Download
118
Deucravacitinib
03/2024
Editorial changes
Download
256
Etanercept
03/2023
No changes
Download
85
Guselkumab
03/2023
No changes
Download
224
Infliximab
03/2023
No changes
Download
101
Ixekizumab
09/2023
New data added
Download
176
Risankizumab
09/2023
New data added
Download
294
Secukinumab
09/2023
New data added
Download
188
Tildrakizumab
03/2023
No changes
Download
144
Ustekinumab
03/2023
No changes
Download
129
Biosimilars
09/2023
New data added
Download
110
Newly approved medications and treatments in the pipeline
10/2021
No changes
Download
260

Last updated
Changes
Download
Psoriatic arthritis
03/2023
New data added, recommendations changed
Download
434
Inflammatory bowel disease
10/2021
Recommendation concerning bimekizumab added
Download
171
Cancer
09/2023
New data added
Download
483
Depression
09/2023
New data added
Download
137
Diabetes Mellitus
09/2023
New data added, recommendations changed
Download
203
Heart disease
03/2023
New data added
Download
231
Kidney disease
03/2023
New data added
Download
122
Neurological diseases
09/2023
New data added
Download
136
Viral Hepatitis
01/2024
Chapter currently under review
Tuberculosis: Screening
09/2023
Editorial changes
Download
199
Tuberculosis: Treatment
09/2023
Editorial changes
Download
210
Wish for child / Pregnancy
10/2021
Time until pregnancy added for bimekizumab
Download
368
Vaccinations
03/2023
Completely new written
Download
266
Inmunogenicity
10/2021
No changes
Download
110

Last updated
Changes
Download
Methods Report
09/2023
Editorial changes
Download
216
Strength and limitations
09/2023
No changes
Download
72
Abbreviations
09/2023
Editorial changes
Download
34